Fourteen-year survival in a case of malignant hypertension under hypotensive drug therapy.
D000328:Adult; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002740:Chlorothiazide / Q000627:therapeutic use; D006145:Guanethidine / Q000627:therapeutic use; D006584:Hexamethonium Compounds / Q000627:therapeutic use; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D006974:Hypertension, Malignant / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D008464:Mecamylamine / Q000627:therapeutic use; D008750:Methyldopa / Q000627:therapeutic use; D010393:Pempidine / Q000627:therapeutic use; D010425:Pentolinium Tartrate / Q000627:therapeutic use; D008517:Phytotherapy; D010946:Plants, Medicinal; D011926:Rauwolfia / Q000627:therapeutic use
D000959:Antihypertensive Agents; D006584:Hexamethonium Compounds; D006852:Hydrochlorothiazide; D006830:Hydralazine; D008750:Methyldopa; D008464:Mecamylamine; D002740:Chlorothiazide; D010425:Pentolinium Tartrate; D010393:Pempidine; D006145:Guanethidine